A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy Participants
ModernaTX, Inc.
ModernaTX, Inc.
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
University of Louisville
Enzon Pharmaceuticals, Inc.